Shows
5th World Sepsis Congress: Sepsis Research and Innovations57: WSC 2021 – Understanding the Different Faces of SepsisSession ‘Understanding the Different Faces of Sepsis’ from the 2021 World Sepsis Congress. Featuring Andrew Argent, Flavia Machado, David Barr, Sophie Yacoub, Arjen Dondorp, Mohammod Chisti, and Vida Hamilton as moderator.
More info: worldsepsiscongress.org2021-05-181h 42
5th World Sepsis Congress: Sepsis Research and Innovations49: WSC Spotlight: Early Identification and Appropriate Clinical Management of Sepsis Saves Lives and Prevents AMRSession 6 from the 2020 WSC Spotlight. Featuring Konrad Reinhart, Shally Awasthi, Arjen Dondorp, Rana Sharara-Chami, and Abdulelah Al-Hawsawi, with closing remarks from Edward Kelley and Niranjan ’Tex’ Kissoon, chaired by Ron Daniels.
More info: wscspotlight.org2020-10-201h 54
5th World Sepsis Congress: Sepsis Research and Innovations27: 2nd WSC: Antimicrobial Therapy and Source Control ISession ‘Antimicrobial Therapy and Source Control I’ from the 2nd World Sepsis Congress. Featuring Mathias Pletz, Jean Chastre, Tobias Welte, Charles Gomersall, John Marshall, Arjen Dondorp, and Alison Fox-Robichaud as chair. More info at www.worldsepsiscongress.org2018-09-271h 29
NDM International ActivitiesThe treatment of severe malariaProfessor Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Current malaria therapies using artesunate aim to kill malaria parasites before they mature. Such medications have high success rates but need to be developed further. Based in Bangkok, Thailand, Professor Arjen Dondorp works on the pathophysiology and treatments of severe malaria, antimalarial drug resistance, and improvements in intensive care practice within developing countries.2014-12-1608 minNDM International ActivitiesThe treatment of severe malariaProfessor Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Current malaria therapies using artesunate aim to kill malaria parasites before they mature. Such medications have high success rates but need to be developed further. Based in Bangkok, Thailand, Professor Arjen Dondorp works on the pathophysiology and treatments of severe malaria, antimalarial drug resistance, and improvements in intensive care practice within developing countries.2014-12-1600 min
MalariaThe treatment of severe malariaProfessor Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Current malaria therapies using artesunate aim to kill malaria parasites before they mature. Such medications have high success rates but need to be developed further. Based in Bangkok, Thailand, Professor Arjen Dondorp works on the pathophysiology and treatments of severe malaria, antimalarial drug resistance, and improvements in intensive care practice within developing countries.2012-02-2108 minMalariaThe treatment of severe malariaProfessor Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Current malaria therapies using artesunate aim to kill malaria parasites before they mature. Such medications have high success rates but need to be developed further. Based in Bangkok, Thailand, Professor Arjen Dondorp works on the pathophysiology and treatments of severe malaria, antimalarial drug resistance, and improvements in intensive care practice within developing countries.2012-02-2108 min
Translational MedicineThe treatment of severe malariaProf. Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Prof Arjen Dondorp is the Deputy Director and Head of Malaria Research at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. His main research interests include the pathophysiology and treatment of severe malaria, antimalarial drug resistance and the improvement of intensive care practice in developing countries.2012-02-2108 minTranslational MedicineThe treatment of severe malariaProf. Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Prof Arjen Dondorp is the Deputy Director and Head of Malaria Research at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. His main research interests include the pathophysiology and treatment of severe malaria, antimalarial drug resistance and the improvement of intensive care practice in developing countries.2012-02-2100 minTranslational MedicineThe treatment of severe malariaProf. Arjen Dondorp tells us about his work on severe malaria and the development of new therapies. Prof Arjen Dondorp is the Deputy Director and Head of Malaria Research at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. His main research interests include the pathophysiology and treatment of severe malaria, antimalarial drug resistance and the improvement of intensive care practice in developing countries.2012-02-2108 min